Generally, multifarious CRP genetic polymorphisms have been identified in different genetic loci, which can alter CRP blood concentrations, including common CRP or new variants as well as promoter polymorphisms; these variants have been associated with an increased risk for lung cancer, coronary heart disease, and other conditions [51,52,53,54,55,56]. This evidence concerns the gene CRP and lung cancer.